International Journal of Drug Policy
Volume 19, Issue 5 , Pages 353-358 , October 2008

Erasing pleasure from public discourse on illicit drugs: On the creation and reproduction of an absence

  • David Moore

      Affiliations

    • Corresponding Author InformationTel.: +61 8 9266 1600; fax: +61 8 9266 1611.

Received 2 April 2007 ,Revised 5 July 2007 ,Accepted 17 July 2007.

References 

  1. Campbell, C. (1987). The romantic ethic and the spirit of modern consumerism. Oxford: Basil Blackwell.
  2. Coveney J, Bunton R. In pursuit of the study of pleasure: Implications for health research and practice. Health. 2003;7(2):161–179
  3. Douglas, M. (1986). How institutions think. London: Routledge and Kegan Paul.
  4. Driscoll, L. (2000). Reconsidering drugs: Mapping Victorian and modern drug discourses. New York: Palgrave.
  5. Elias, N. (2000). The civilizing process (Revised ed.). Oxford: Blackwell.
  6. Fitzgerald JL, Louie R, Rosenthal D, Crofts N. The meaning of the rush for initiates to injecting drug use. Contemporary Drug Problems. 1999;26(3):481–504
  7. Holt, M. (2005). Young people and illicit drug use in Australia. Social Research Issues Paper 3 (National Centre in HIV Social Research). Retrieved 21st December 2006 from http://nchsr.arts.unsw.edu.au/pdf%20reports/SRIP03.pdf.
  8. Keane H. Adventures of the addicted brain. Australian Feminist Studies. 1999;14(29):63–76
  9. Keane, H. (2002). What's wrong with addiction? Melbourne: Melbourne University Press.
  10. Kerr T, Small W, Moore D, Wood E. A micro-environmental intervention to reduce the harms associated with drug-related overdose: Evidence from the evaluation of Vancouver's safer injection facility. International Journal of Drug Policy. 2007;18(1):37–45
  11. Lupton, D. (1995). The imperative of health: Public health and the regulated body. London: Sage.
  12. MacLean S. ‘It might be a scummy-arsed drug but it's a sick buzz’: Chroming and pleasure. Contemporary Drug Problems. 2005;32(2):295–318
  13. Maher L. Sexed work: Gender, race and resistance in a Brooklyn drug market. Oxford: Clarendon Press; 1997;
  14. Manderson D. Possessed: Drug policy, witchcraft and belief. Cultural Studies. 2005;19(1):36–63
  15. Martin-Soelch C, Leenders KL, Chevalley A-F, Missimer J, Künig G. Reward mechanisms in the brain and their role in dependence: Evidence from neurophysiological and neuroimaging studies.. Brain Research Reviews. 2001;36:139–149
  16. Measham F. The decline of ecstasy, the rise of ‘binge’ drinking and the persistence of pleasure. Probation Journal. 2004;51(4):309–326
  17. Miller P, Moore D, Strang J. The regulation of research by funding bodies: An emerging ethical issue for the alcohol and other drug sector?. International Journal of Drug Policy. 2006;17(1):12–16
  18. Moore D, Fraser S. Putting at risk what we know: Reflecting on the drug-using subject in harm reduction and its political implications. Social Science and Medicine. 2006;62(12):3035–3047
  19. Mugford, S. (1988). Pathology, pleasure, profit and the state: Towards an integrated theory of drug use. Paper presented at the Australian and New Zealand Society of Criminology Annual Conference, Sydney, August 22.
  20. O’Malley P, Mugford S. The demand for intoxicating commodities: Implications for the ‘War on Drugs’. Social Justice. 1991;18(4):49–75
  21. O’Malley P, Valverde M. Pleasure, freedom and drugs: The uses of ‘pleasure’ in liberal governance of drug and alcohol consumption. Sociology. 2004;38(1):25–42
  22. Russell JA. The return of pleasure. Cognition and Emotion. 2003;17(2):161–165
  23. Stallybrass, P., & White, A. (1986). The politics and poetics of transgression. London: Methuen.
  24. Stewart, T. (1996). The heroin users. London: Pandora.
  25. Valverde M. Experience and truthtelling: Intoxicated autobiography and ethical subjectivity. Outlines. 2002;1:3–18
  26. Wacquant LD. Towards a reflexive sociology: A workshop with Pierre Bourdieu. Sociological Theory. 1989;7(1):26–63
  27. Zuckerman, M. (1979). Sensation seeking: Beyond the optimal level of arousal. Hillsdale, N.J.: L. Erlbaum Associates.

PII: S0955-3959(07)00143-0

doi: 10.1016/j.drugpo.2007.07.004

International Journal of Drug Policy
Volume 19, Issue 5 , Pages 353-358 , October 2008